The
slide to be stained for
SMH
comprised:
1. Tonsil, 2. Esophagus, 3. Breast hyperplasia, 4 – 5. Breast ductal
carcinoma
All tissues were fixed in 10% neutral buffered formalin.
Criteria for assessing a SMH staining as optimal included:
- A moderate to strong and distinct
cytoplasmic staining of the vascular smooth muscle cells in all
the specimens and the esophageal lamina
muscularis mucosae.
- An at least weak but distinct cytoplasmic
staining of dendritic follicular cells
of
the germinal centres in the tonsil.
- A moderate to strong, distinct
cytoplasmic staining of the glandular myoepithelial cells of
the breast hyperplasia and in the remnants of the normal glands
in the two breast carcinomas.
19 laboratories participated in this
assessment. 79 % achieved a sufficient mark. In table 1 the
antibodies (Abs) used and marks are summarized.
Table 1.
Abs and
assessment marks
for SMH, run B8
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
|
mAb clone
SMMS-1 |
14 |
Dako |
5 |
5 |
3 |
1 |
71 % |
75 % |
|
mAb clone S131 |
1 |
Novocastra |
1 |
0 |
0 |
0 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
mAb clone
SMMS-1,
IR066 |
1 |
Dako |
0 |
1 |
0 |
0 |
- |
- |
mAb
clone SMMS-1,
760-2704 |
2
1 |
Ventana
Cell Marque |
2 |
1 |
0 |
0 |
- |
- |
|
Total |
19 |
|
8 |
7 |
3 |
1 |
- |
- |
|
Proportion |
|
|
42 % |
37 % |
16 % |
5 % |
79 % |
- |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Abs
mAb clone SMMS-1: the protocols giving an optimal result were
all based on heat induced epitope retrieval (HIER) using either
Tris-EDTA/EGTA pH 9 (2/2)*, Target Retrieval Solution pH 9 (EnVision
FLEX TRS high pH, Dako), (2/2) or Cell Conditioning 1 (BenchMark,
Ventana) (1/4). The mAb was typically diluted in the range of 1:200–
1:1.500 depending on the total sensitivity of the protocol employed.
Using these protocol settings 6 out of 8 (75 %) laboratories
produced a sufficient staining (optimal or good).
* (number of optimal results/number of
laboratories using this buffer)
mAb clone S131: the protocol giving an optimal result was
based on heat induced epitope retrieval (HIER) using Bond Epitope
Retrieval Solution 2 (Bond, Leica) and a dilution of 1:25 of the
mAb.
Ready-To-Use Abs
mAb clone SMMS-1 (Ventana, prod. no 760-2704): One optimal
protocol was based on HIER using standard Cell Conditioning 1
(Benchmark, Ventana), an incubation time of 32 min in the primary Ab
and UltraView as the detection system. The other optimal protocol
was based on a combined pre-treatment, using HIER in standard Cell
Conditioning 1 followed by Protease 3 for 4 min. The primary Ab was
incubated for 60 min and iView was used as the detection system.
The most frequent causes of insufficient stains were:
- Insufficient HIER – too short efficient heating time
- Use of Citrate pH 6 as HIER buffer.
In this assessment the prevalent feature of an insufficient staining
was a generally too weak staining of the structures supposed to be
demonstrated. This pattern was in particular observed in the
myoepithelial cells of the glands in the breast hyperplasia, whereas
virtually all laboratories could demonstrate SMH in the smooth
muscle cells of lamina muscularis mucosae in the esophagus and in
large vessels. It was seen, that both HIER and a combination of HIER
followed by a mild proteolytic pre-treatment could be used to obtain
an optimal result with the most commonly used mAb clone SMMS-1. When
HIER was used alone as pre-treatment, it seemed to be mandatory to
use an alkaline buffer, as none of the six laboratories using
Citrate pH 6 obtained an optimal result (3 were assessed as good, 3
as insufficient) whereas 6 laboratories out of 11
using an alkaline buffer for HIER obtained an optimal result.
As control, the tonsil displayed the most informative reaction
pattern as critical staining indicator for SMH. In the optimal
protocols the dendritic follicular cells in the germinal centres showed a weak to moderate but distinct reaction,
while the vascular smooth muscle cells showed a strong reaction. In
the stains deemed too weak and insufficient the dendritic follicular
cells typically were negative.
Conclusion
The mAb clones SMMS-1 and S131 are both recommendable Abs for the
demonstration of SMH. HIER in an alkaline buffer is mandatory to
obtain an optimal result. Tonsil is an appropriate control tissue: The
dendritic follicular cells in the germinal centres must show at
least a weak staining reaction without any staining of the
lymphocytes. |
|
Fig. 1a. Optimal SMH
staining of the tonsil using the mAb clone SMMS-1 correctly
calibrated and with HIER in an alkaline buffer (Tris-EDTA pH 9).
Both the smooth muscle cells of the vessels and dendritic follicular
cells of the germinal centre show a moderate and distinct
staining. No staining is seen in the lymphocytes. |
Fig. 1b. Insufficient SMH
staining of the tonsil using the mAb clone SMMS-1 too diluted.
Only the smooth muscle cells of the vessels are demonstrated, while
the dendritic follicular cels of the germinal
centre are virtually negative.
Also compare with Fig. 2b - same protocol. |